Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …

Major depressive disorder (MDD) is a common, debilitating, phenotypically heterogeneous
disorder with heritability ranges from 30% to 50%. Compared to other psychiatric disorders …

Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

Depression is a heterogeneous and etiologically complex psychiatric syndrome, not a
unitary disease entity, encompassing a broad spectrum of psychopathology arising from …

Objective To understand the mental health response to repeated and prolonged stress
during the COVID-19 related lockdown and the role of specific health behaviors to buffer …

Behavior genetics studies how genetic differences among people contribute to differences in
their psychology and behavior. Here, I describe how the conclusions and methods of …

Multiple studies on the pathomechanisms of depressive disorder and antidepressants have
been reported. However, literature involving scientometric analysis of depressive disorder is …

Major Depressive Disorder (MDD) is a highly prevalent psychiatric disorder worldwide. It
causes individual suffering, loss of productivity, increased health care costs and high suicide …

Objective High cardiovascular reactions to psychological stress are associated with the
development of hypertension, systemic atherosclerosis, and cardiovascular disease …

Neuroticism--the tendency to experience negative emotions, along with the perception that
the world is filled with stressful, unmanageable challenges--is strongly associated with …